Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2020 Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Jeanie Herbert - Head of Investor Relations Mark Foley - President & Chief Executive Officer Toby Schilke - Chief Financial Officer Dustin Sjuts - Chief Commercial Officer, Therapeutics & Aesthetics Conference Call Participants Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Terence Flynn - Goldman Sachs David Amsellem - Piper Sandler Kush Patel - Guggenheim Tim Lugo - William ...